Ke Cheng, Ph.D.

Alan L. Kaganov Professor of Biomedical Engineering, Columbia University. Stem cells, biomaterials, and exosomes for regeneration. Views are mine.

[Ke Cheng, Ph.D. @KeChengLab]

Excited to co-chair AAEV2026 this November with @SusmitaSahooPhD. We have a great line up of speakers and editors. Abstract submission and early bird registration deadline is approaching.

[American Association of Extracellular Vesicles @AAEV_org]

🌟 AAEV 2026 is coming to Jersey City! 🌟
Join us Nov 11–15, 2026 for an exciting program featuring renowned keynote & invited speakers, Co-Chairs Ke Cheng & Susmita Sahoo, and a special Editors’ Panel with editors from Nature Biomedical Engineering, Cell Stem Cell, and Nature Nanotechnology.
🧬 Cutting-edge EV science
🎤 Outstanding speakers
📝 Meet leading journal editors
🤝 Connect with the EV community
📍 Jersey City, NJ
📅 Nov 11–15, 2026
Don’t miss #AAEV2026! 🫧
https://t.co/CUUXeigMcc
#ExtracellularVesicles #EVs #Exosomes #EVResearch #AnnualMeeting

[Ke Cheng, Ph.D. @KeChengLab]

Many thanks to @NatureBiotech for selecting our work as the front cover. Congratulations again to @ShuoL_ and the entire team.

[Nature Biotechnology @NatureBiotech]

The October issue is live https://t.co/YS7jDT2nKn

On the cover, engineered inhalable exosomes display a bispecific T cell activator targeting a cancer cell along with a T cell. PD1 and FZD on the exosomes block tumor-cell PD-L1 signaling and neutralize tumor-secreted Wnt, respectively https://t.co/rbmV1rmxYO
https://t.co/3Vr4tlyzLv

[American Association of Extracellular Vesicles @AAEV_org]

📢 AAEV 2026 Deadline Extension!
In response to requests from researchers, we’re extending the following deadlines from Sept 15 → Sept 25:
🐦 Early Bird Registration
📝 Abstract Submission
🏆 Award Nominations
⚠️ Abstract review begins this week. Late abstracts may still be accepted for poster presentations and remain eligible for poster awards, but may not be considered for oral presentations.
Don’t miss the extended deadline—submit by Sept 25!
#AAEV2026 #ExtracellularVesicles #EVs #AbstractSubmission #EarlyBird #ScientificConference
ChatGPT can make mistakes. Workspace data isn't used to train models.

[American Association of Extracellular Vesicles @AAEV_org]

We’re thrilled to announce that Dr. David Lyden (Weill Cornell Medicine) will deliver the Opening Plenary Lecture at the AAEV 2026 Annual Meeting!

A pioneer of the pre-metastatic niche concept, Dr. Lyden’s groundbreaking work revealed how tumor-derived extracellular vesicles orchestrate systemic metastasis and organ-specific spread—reshaping our understanding of cancer biology.

Join us to hear insights from a global leader whose discoveries span EV biology, metastasis, and translational biomarkers.

#AAEV2026 #ExtracellularVesicles #CancerResearch #Metastasis

[Ke Cheng, Ph.D. @KeChengLab]

I am deeply grateful to all my mentees and mentors for the @aimbe professional impact award for mentoring. This mentoring award is because of you and for you.

[Ke Cheng, Ph.D. @KeChengLab]

Congratulations to Kaiyue Zhang on the publication @ScienceMagazine. In the paper, we built an “RNA factory” on muscle for heart repair. https://t.co/DRDhOLKbLl

[Ke Cheng, Ph.D. @KeChengLab]

Look forward to AAEV2026 in the neighborhood!

[American Association of Extracellular Vesicles @AAEV_org]

Save the Date: AAEV Annual Meeting | Nov 12–15, 2026 | NYC Metropolitan Area
We are pleased to announce that the American Association of Extracellular Vesicles (AAEV) Annual Meeting will take place November 12–15, 2026 in The Westin Jersey City Newport in the New York City Metropolitan Area.
Find more information: https://t.co/vzGvIvQxy9

[Ke Cheng, Ph.D. @KeChengLab]

Congratulations to Shuo Liu on the publication in @NatureBiotech. An elegant and impactful study showcasing the power of engineered exosomes to overcome immunotherapy resistance.
https://t.co/Ns3ApXUfab

[Ke Cheng, Ph.D. @KeChengLab]

Huge congratulations to the Capricor team. Proud to have been part of the 1st academic IND in the early days, leading a young team out of a modest tissue-culture room. 16 years: from the first IND to this Phase 3 success - remarkable.

[Capricor Therapeutics @Capricor]

Breaking: Capricor is extremely pleased to announce positive topline results from our pivotal Phase 3 HOPE-3 clinical study evaluating Deramiocel in Duchenne muscular dystrophy.
HOPE-3 met its primary endpoint and key cardiac secondary endpoint, with all Type 1 error–controlled secondary endpoints also achieving statistical significance. Deramiocel maintained a favorable safety and tolerability profile consistent with prior studies.
We are grateful to the patients, families, investigators and partners who made this milestone possible.
Read the full announcement: https://t.co/i0fi5S6Nxn
Join our conference call and webcast today at 8:00 a.m. ET. https://t.co/JcVqV7Ubld
$CAPR #Duchenne #DMD #Deramiocel #HOPE3 #CellTherapy #RareDiseaseAdvocate

[Ke Cheng, Ph.D. @KeChengLab]

Honored to receive the AAEV Founder’s Award and to be inducted into the inaugural class of Fellow of AAEV at the 2025 @AAEV_org Annual Conference in Salt Lake City. Grateful to my team, collaborators, and the EV community for their support and commitment to advancing EV research.

[Ke Cheng, Ph.D. @KeChengLab]

AAEV 2025 kicks off in just 2 hours ！🎇🎇we look forward to seeing you at the U Utah Alumni House Salt Lake City 🏔️🏔️🏔️

[Ke Cheng, Ph.D. @KeChengLab]

A truly inspiring visit to the @VU_EVresearch annual retreat. Many thanks to Alissa Weaver co-chair of the 2024 @AAEV_org for the invitation. Enjoyed the panel with @hailingj1 and Brain Eliceiri.

[Ke Cheng, Ph.D. @KeChengLab]

@JHElisseeff We are so thrilled to have you Jennifer!

[American Association of Extracellular Vesicles @AAEV_org]

🚨 LAST DAY to Submit Your Abstract! 🚨

Don’t miss your chance to present at #AAEV2025 in Salt Lake City, Nov 20–23!
Outstanding abstracts will be considered for oral presentations and poster awards.
📅 Deadline: TODAY (Aug 15)
📍 Submit now: https://t.co/HlSWn0Zl18

#ExtracellularVesicles #CallForAbstract
#AAEV #Exosome

[Ke Cheng, Ph.D. @KeChengLab]

Abstract is due tomorrow !

[American Association of Extracellular Vesicles @AAEV_org]

⏳ Final Reminder!
The AAEV2025 abstract submission deadline is TOMORROW (Aug 15)!
Outstanding abstracts will be considered for oral presentations and poster awards.
Submit now: https://t.co/0AqcLcrLOL
#AAEV2025 #ExtracellularVesicles #CallForAbstract #ISEV #Exosome

[Ke Cheng, Ph.D. @KeChengLab]

See you in Salt Lake City !

[American Association of Extracellular Vesicles @AAEV_org]

⏳ Final Reminder!
The AAEV2025 abstract submission deadline is TOMORROW (Aug 15)!
Don’t miss your chance to present your work in Salt Lake City this November.
Outstanding abstracts will be considered for oral presentations and poster awards.
Submit now: https://t.co/a7eB8pBLwx

[American Association of Extracellular Vesicles @AAEV_org]

⏳ Final Reminder!
The AAEV2025 abstract submission deadline is TOMORROW (Aug 15)!
Don’t miss your chance to present your work in Salt Lake City this November.
Outstanding abstracts will be considered for oral presentations and poster awards.
Submit now: https://t.co/a7eB8pBLwx

[Ke Cheng, Ph.D. @KeChengLab]

Great talk by Eduardo on the discovery arch from cell therapies to RNA drugs for heart repair in the CVBE-CNIC meeting @MarbanLab “mining RNAs from cells”

[Ke Cheng, Ph.D. @KeChengLab]

Excited to share our @NatureMaterials News & Views: @zhang_weih3053 from @KeChengLab highlights an inhalable nanoplatform that targets inflamed lung tissue, self-assembles into catalytic fibrils, reduces ROS, and alleviates viral pneumonia symptoms.

[Ke Cheng, Ph.D. @KeChengLab]

@yizhoudonglab @IcahnMountSinai @IcahnInstitute @SinaiImmunol @TischCancer Congratulations Yizhou!!!